Top ▲

Interleukin-1 receptor-like 2

Click here for help

Immunopharmacology Ligand Target has curated data in GtoImmuPdb

Target id: 1736

Nomenclature: Interleukin-1 receptor-like 2

Family: Immunoglobulin-like family of IL-1 receptors

Annotation status:  image of a red circle Awaiting annotation  » Email us

Quaternary Structure: Complexes
Interleukin-36 receptor
Gene and Protein Information Click here for help
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human 1 575 2q12.1 IL36R interleukin 36 receptor
Mouse 1 574 1 B Il1rl2 interleukin 1 receptor-like 2
Rat 1 561 9q22 Il1rl2 interleukin 1 receptor-like 2
Previous and Unofficial Names Click here for help
IL1RRP2 | interleukin-1 receptor-related protein 2 | IL1RL2 | interleukin 1 receptor like 2
Database Links Click here for help
Alphafold
CATH/Gene3D
ChEMBL Target
Ensembl Gene
Entrez Gene
Human Protein Atlas
KEGG Gene
OMIM
Pharos
UniProtKB
Wikipedia

Download all structure-activity data for this target as a CSV file go icon to follow link

Antibodies
Key to terms and symbols Click column headers to sort
Antibody Sp. Action Value Parameter Reference
MAB92 Peptide Primary target of this compound Immunopharmacology Ligand Hs Binding 10.6 pKd 3
⤷ pKd 10.6 (Kd 2x10-11 M) [3]
Description: Binding affinity for recombinant hIL-36R by SPR
spesolimab Peptide Approved drug Immunopharmacology Ligand Hs Binding ~10.5 pKd 1
⤷ pKd ~10.5 (Kd ~3x10-11 M) [1]
imsidolimab Peptide Click here for species-specific activity table Immunopharmacology Ligand Hs Binding - - 2
⤷ [2]
Immunopharmacology Comments
Interleukin-1 receptor-like 2 is one of the subunits of the functional receptor for IL-36.

An antibody that mimics IL-36RA's antagonist activity at the IL-36 receptor (MAB92) has been described [3]. MAB92 inhibits proinflammatory cytokine production in primary human keratinocytes and dermal fibroblasts in vitro. Such IL-36 antagonist antibodies are predicted to present a novel therapeutic mechanism for the treatment of epithelial cell-mediated inflammation, in particular for DITRA (deficiency of IL-36 receptor antagonist) type syndromes caused by functionally inactivating mutations in IL-36RA which leave the pro-inflammatory activity of IL-36 receptor ligands unopposed.
Immuno Process Associations
Immuno Process:  Cytokine production & signalling
GO Annotations:  Associated to 3 GO processes
GO:0004908 interleukin-1 receptor activity TAS
GO:1900017 positive regulation of cytokine production involved in inflammatory response NAS
click arrow to show/hide IEA associations
GO:0004909 interleukin-1, type I, activating receptor activity IEA
Immuno Process:  Immune regulation
GO Annotations:  Associated to 3 GO processes
GO:0050727 regulation of inflammatory response IBA
GO:0050728 negative regulation of inflammatory response NAS
GO:1900017 positive regulation of cytokine production involved in inflammatory response NAS
Immuno Process:  Inflammation
GO Annotations:  Associated to 3 GO processes
GO:0050727 regulation of inflammatory response IBA
GO:0050728 negative regulation of inflammatory response NAS
GO:1900017 positive regulation of cytokine production involved in inflammatory response NAS

References

Show »

1. Brown SE, Canada K, Chlewicki L, Howell M, Mennerich D, Woska JR. (2015) Anti IL-36R antibodies. Patent number: US9023995B2. Assignee: Boehringer Ingelheim International GmbH. Priority date: 16/11/2011. Publication date: 05/05/2015.

2. Freitas E, Rodrigues MA, Torres T. (2020) Diagnosis, Screening and Treatment of Patients with Palmoplantar Pustulosis (PPP): A Review of Current Practices and Recommendations. Clin Cosmet Investig Dermatol, 13: 561-578. [PMID:32884319]

3. Ganesan R, Raymond EL, Mennerich D, Woska Jr JR, Caviness G, Grimaldi C, Ahlberg J, Perez R, Roberts S, Yang D et al.. (2017) Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies. MAbs, 9 (7): 1143-1154. [PMID:28726542]

Citation information

Last modified on 01/06/2026.

The citation format for the published version of this page will be:

Immunoglobulin-like family of IL-1 receptors: Interleukin-1 receptor-like 2. Last modified on 01/06/2026. Accessed on 17/11/2026. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1736.